Table 3.
Ipilimumab | ||||||
---|---|---|---|---|---|---|
Pre-treatment | Week 6 | |||||
n | HR (95% CI) | p-value | n | HR (95% CI) | p-value | |
MDSC ≤ 14.9% | 68 | 0.47 (0.23 – 0.94) | 0.033 | 63 | 0.38 (0.18 – 0.81) | 0.012 |
ALC ≥1000 cells/µl | - | - | - | 63 | 0.21 (0.10 – 0.46) | < 0.001 |
LDH < 250 | 68 | 0.38 (0.21 – 0.69) | 0.002 | 63 | 0.29 (0.15 – 0.56) | < 0.001 |